--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--------
--------
--------
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
SLXN Silexion Therapeutics
- 2.440
- +0.020+0.83%
Close Dec 20 16:00 ET
- 2.400
- -0.040-1.64%
Post 19:58 ET
3.91MMarket Cap-0.13P/E (TTM)
2.570High2.120Low264.15KVolume2.120Open2.420Pre Close621.22KTurnover26.58%Turnover RatioLossP/E (Static)1.60MShares122.01852wk High-0.86P/B2.43MFloat Cap1.86352wk Low--Dividend TTM993.97KShs Float122.013Historical High--Div YieldTTM18.60%Amplitude1.863Historical Low2.351Avg Price1Lot Size
Silexion Therapeutics Key Stats
Silexion Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Silexion Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data